Evaluation of the Physiodoloris Pain Monitor in Patients With Complex Regional Pain Syndrome
NCT02663284
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
30
Enrollment
OTHER
Sponsor class
Conditions
Complex Regional Pain Syndrome
Interventions
DRUG:
Ropivacaine 0.5%
Sponsor
Hopital Foch